DNA Ginkgo Bioworks
- 0.542
- +0.013+2.48%
- 0.550
- +0.008+1.51%
Ginkgo Bioworks News
Express News | NYSE Order Imbalance 368996.0 Shares on Sell Side
What You Can Learn From Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) P/S After Its 34% Share Price Crash
To the annoyance of some shareholders, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) shares are down a considerable 34% in the last month, which continues a horrid run for the company.
Watching Ginkgo Bioworks Holdings; Shares Trading Lower After A Popular Newsletter Issued a Report On The Company
Watching Ginkgo Bioworks Holdings; Shares Trading Lower After A Popular Newsletter Issued a Report On The Company
Ginkgo Bioworks Stock: Bull Vs. Bear
Russell 3000: Inovio, Ocugen Among Healthcare Additions; Assertio, Ginkgo Bioworks Among Deletions
Express News | NYSE Order Imbalance 519974.0 Shares on Buy Side
Should You Buy the Dip on Ginkgo Bioworks Stock?
Express News | NYSE Order Imbalance 167300.0 Shares on Buy Side
Express News | NYSE Order Imbalance 298350.0 Shares on Buy Side
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
Cathie Wood's flagship ARK Innovation ETF (NYSE:ARKK) has been navigating through significant losses, showcasing the challenges faced by some of its major holdings. What Happened: Since its peak in Fe
3 Things You Need to Know If You Buy Ginkgo Bioworks Today
Down 72%. Is Ginkgo Bioworks a Buy on the Dip?
Express News | NYSE Order Imbalance 284743.0 Shares on Sell Side
Express News | NYSE Order Imbalance 120666.0 Shares on Buy Side
Express News | NYSE Order Imbalance 87007.0 Shares on Buy Side
Ginkgo Bioworks(DNA.US) Director Sells US$220.03K in Common Stock
$Ginkgo Bioworks(DNA.US)$ Director DEKKERS MARIJN E sold 265K shares of common stock on May 16, 2024 at an average price of $0.8303 for a total value of $220.03K.Source: Announcement What is statement
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
Investment Advisor Says 'Throwing Random Darts At Tickers' Would Beat ARKK As Cathie Wood's Flagship Fund Lags Far Behind Soaring Market: 'How Do They Do It?!'
Ark Investment Management, led by star investor Cathie Wood, is facing a harsh reality in 2024. While the broader market is hitting record highs, Ark's actively managed funds are lagging far behind, r
Is Ginkgo Bioworks Holdings Stock a Buy?
Ginkgo Bioworks(DNA.US) Director Buys US$514.75K in Common Stock
$Ginkgo Bioworks(DNA.US)$ Director Sankar Shyam purchased 625K shares of common stock on May 15, 2024 at an average price of $0.8236 for a total value of $514.75K.Source: Announcement What is statemen
Analysis
Price Target
No Data
